Literature DB >> 23065075

Effects of statins and cholesterol on memory functions in mice.

Ravindra M Ghodke1, Nagesh Tour, Kshama Devi.   

Abstract

Studies on influence of lipid lowering therapies have generated wide controversial results on the role of cholesterol on memory function. However recent studies revealed that cholesterol lowering treatment substantially reduce the risk of dementia. The objectives of this study were to analyze the effect of statins on memory function and to establish the relationship between increase/decrease in cholesterol synthesis, total cholesterol level and memory function in animals. We examined the relationship between biosynthesis of cholesterol and memory function using two statins (lipophilic simvastatin and hydrophilic pravastatin) and high cholesterol diet in mice for 15 days and 4 months. Memory performance was evaluated with two different behavioral tests and various biochemical parameters such as serum cholesterol, whole brain cholesterol, brain 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) activity and brain acetylcholine esterase (AChE) activity. We found that statin treatment for 4 months, but not for 15 days, showed significant improvement in memory function whereas high cholesterol diet showed significant impairment of memory. However long-term statin treatment showed significant decrease in serum cholesterol level as well as brain AChE level. Moreover high cholesterol diet showed significant decrease in memory function with an increase in serum cholesterol level as well as brain AChE level. There is no direct correlation between brain cholesterol level, as well as HMG-CoA activity with memory function regulation. However there is definite link between plasma cholesterol level and AChE level. A long-standing plasma cholesterol alteration may be essential to regulate memory function which in turn might be mediated through AChE modulated pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065075     DOI: 10.1007/s11011-012-9343-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  35 in total

1.  Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage.

Authors:  Matthew J McGirt; John R Lynch; Augusto Parra; Huaxin Sheng; Robert D Pearlstein; Daniel T Laskowitz; Dale A Pelligrino; David S Warner
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Brain cholesterol turnover required for geranylgeraniol production and learning in mice.

Authors:  Tiina J Kotti; Denise M O Ramirez; Brad E Pfeiffer; Kimberly M Huber; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

Review 3.  Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.

Authors:  Roger M Lane; Martin R Farlow
Journal:  J Lipid Res       Date:  2005-02-16       Impact factor: 5.922

4.  Two time windows of anisomycin-induced amnesia for inhibitory avoidance training in rats: protection from amnesia by pretraining but not pre-exposure to the task apparatus.

Authors:  J Quevedo; M R Vianna; R Roesler; F de-Paris; I Izquierdo; S P Rose
Journal:  Learn Mem       Date:  1999 Nov-Dec       Impact factor: 2.460

5.  Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

Authors:  T Koga; Y Shimada; M Kuroda; Y Tsujita; K Hasegawa; M Yamazaki
Journal:  Biochim Biophys Acta       Date:  1990-07-16

6.  Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice.

Authors:  J Itoh; T Nabeshima; T Kameyama
Journal:  Eur J Pharmacol       Date:  1991-02-26       Impact factor: 4.432

7.  Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.

Authors:  Karin M Thelen; Katharina M Rentsch; Ursula Gutteck; Maura Heverin; Maria Olin; Ulla Andersson; Arnold von Eckardstein; Ingemar Björkhem; Dieter Lütjohann
Journal:  J Pharmacol Exp Ther       Date:  2005-11-10       Impact factor: 4.030

8.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

9.  Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment.

Authors:  Cornelia Franke; Michael Nöldner; Reham Abdel-Kader; Leslie N Johnson-Anuna; W Gibson Wood; Walter E Müller; Gunter P Eckert
Journal:  Neurobiol Dis       Date:  2006-12-06       Impact factor: 5.996

10.  Differential effects of statins and alendronate on cholinesterases in serum and brain of rats.

Authors:  L Cibicková; V Palicka; N Cibicek; E Cermáková; S Micuda; L Bartosová; D Jun
Journal:  Physiol Res       Date:  2006-11-06       Impact factor: 1.881

View more
  8 in total

1.  Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.

Authors:  Carmen Infante-Garcia; Juan Jose Ramos-Rodriguez; Carmen Hierro-Bujalance; Esperanza Ortegon; Eleanor Pickett; Rosemary Jackson; Fernando Hernandez-Pacho; Tara Spires-Jones; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2017-12-09       Impact factor: 5.590

2.  Which statin worked best to achieve lipid level targets in a European registry? A post-hoc analysis of the EUROASPIRE III for coronary heart disease patients.

Authors:  Fahad Alnouri; David Wood; Kornelia Kotseva; Mohamed E A Ibrahim
Journal:  J Saudi Heart Assoc       Date:  2014-05-04

Review 3.  Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors:  Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

4.  Atorvastatin ameliorates depressive behaviors and neuroinflammatory in streptozotocin-induced diabetic mice.

Authors:  Zhang Hai-Na; Yu Xu-Ben; Tang Cong-Rong; Cao Yan-Cheng; Yang Fan; Xu Lei-Mei; Sun Ruo-Lan; Wang Ye-Xuan; Liang Jing
Journal:  Psychopharmacology (Berl)       Date:  2019-11-30       Impact factor: 4.530

5.  Hypercholesterolemia induces short-term spatial memory impairments in mice: up-regulation of acetylcholinesterase activity as an early and causal event?

Authors:  Eduardo Luiz Gasnhar Moreira; Jade de Oliveira; Daiane Fátima Engel; Roger Walz; Andreza Fabro de Bem; Marcelo Farina; Rui Daniel S Prediger
Journal:  J Neural Transm (Vienna)       Date:  2013-10-29       Impact factor: 3.575

6.  Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice.

Authors:  Rajib Paul; Anupom Borah
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

Review 7.  Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal.

Authors:  Aditi Bhat; Harshita Dalvi; Harsha Jain; Nagarjun Rangaraj; Shashi Bala Singh; Saurabh Srivastava
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-12-31

8.  Membrane Microdomain Disassembly Inhibits MRSA Antibiotic Resistance.

Authors:  Esther García-Fernández; Gudrun Koch; Rabea M Wagner; Agnes Fekete; Stephanie T Stengel; Johannes Schneider; Benjamin Mielich-Süss; Sebastian Geibel; Sebastian M Markert; Christian Stigloher; Daniel Lopez
Journal:  Cell       Date:  2017-11-02       Impact factor: 41.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.